The Bone Regeneration Material Market, estimated at USD 2.86 Bn in 2025, is expected to exhibit a CAGR of 4.6% and reach USD 3.92 Bn by 2032.
The market growth is fueled by rising demand for advanced biotechnology solutions that improve healthcare outcomes, along with increasing adoption in areas such as drug development, diagnostics, and personalized medicine. Innovations in genomics, cell and gene therapies, and biomanufacturing, supported by strong R&D investments, are enhancing treatment effectiveness, efficiency, and accessibility. Furthermore, favorable regulatory support, strategic collaborations, and the growing focus on precision medicine are accelerating market expansion and opening new opportunities for industry participants.
Key market players are focusing on adopting growth strategies such as the launch of new products, which will drive the global bone regeneration material market. For instance, In June 2025, Lithoz, the technology leader for 3D printers, materials, and solutions for the industrial production of high-performance ceramics in the U.S., announced the launch of its new LithaBone HA 480 material for 3D printed bone replacements.
Global Bone Regeneration Material Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025, as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems with regard to the transportation of things from one place to another.
COVID-19 had a positive impact on the global Bone Regeneration Material market. A research study published by the Spine Journal in December 2025, titled "COVID-19 pandemic and elective spinal surgery cancelations: what happens to the patients?" stated that due to the reallocation of resources to the care of COVID-19 patients, the COVID-19 pandemic resulted in a suspension of elective procedures. Following the start of elective surgeries, a considerable number of patients continued to postpone surgery, with many still waiting to be rescheduled, potentially prolonging their discomfort and impairment of function. The study concluded that over one-third of the elective spine procedures that were canceled due to COVID-19 had not been performed in the eight months since the procedures were resumed.
Global Bone Regeneration Material Market: Key Developments
On July 11, 2025, Lithoz a company specializes in the development and production of materials and additive manufacturing systems for 3D printing high-performance ceramics, announced a long-term partnership with New York-based biomaterials specialist Himed, as the companies join forces to accelerate innovation and research into the 3D printing of medical-grade bioceramics.
In June 2025, Ethicon, Inc., which is part of the Johnson & Johnson family of healthcare medical companies focusing on professional surgery transformation solutions, announced that the National Institute for Health and Excellence (NICE) issued new medical technology guidance that recommends the use of plus sutures developed by the company in surgeries within the National Health Service. This is to avoid the rising occurrence of surgical site infections, and Plus sutures are the only sutures that offer antibacterial protection. The electrosurgical devices segment is expected to be the fastest-growing segment during the forecast period